Canada’s Microbix Biosystems To Help China Become World Vaccine Powerhouse
This article was originally published in PharmAsia News
BEIJING - Toronto-headquartered Microbix Biosystems plans to begin building Asia's largest influenza vaccine production facility near the birthplace of China's Chairman Mao Zedong in 2009, in a partnership with provincial leaders, according to Microbix CEO Bill Gastle
You may also be interested in...
China’s Health System Reforms Set To Spark Hospital Construction Boom And Boost Medical Device Makers
[Editor's note: This is part two in a new series on China's wide-ranging plans to reform the country's health system, including its hospitals, insurance schemes and access to medicines. Part one appeared in PharmAsia News on Oct. 30, 2008.]
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).